Libya vs Saint Lucia: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Libya
0.2%
in 2024
Saint Lucia
0.2%
in 2024
Libya rank
78th
Saint Lucia rank
78th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Libya
- Saint Lucia
How they compare
Libya currently reports 0.2% against 0.2% in Saint Lucia, a difference of 0.0%.
Across all 10 years both countries report, Saint Lucia has been ahead every year.
Libya ranks 78th and Saint Lucia ranks 78th of 215 countries.
Saint Lucia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Libya | Saint Lucia | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.2% | 0.3% | 0.1% | Saint Lucia |
| 2020s | 0.2% | 0.2% | 0.0% | — |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Libya or Saint Lucia?
- Libya, at 0.2% against 0.2% in Saint Lucia as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Libya and Saint Lucia?
- 0.0%, with Libya ahead.
- How many years of comparable data are there for Libya and Saint Lucia?
- 10 years are reported by both, from 2015 to 2024.
- How do Libya and Saint Lucia rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Libya ranks 78th and Saint Lucia ranks 78th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.